P77.05 Phase II Study of Imprime PGG and Pembrolizumab in Stage IV NSCLC After Progression on First-Line Therapy: BTCRC-LUN15-017

Authors :: K. Kennedy
Mary Pasquinelli
A. Shergill
Lawrence Eric Feldman
Jyoti Malhotra
Muhammad Furqan
E. Sisel
Li Liu
Source :: Journal of Thoracic Oncology. 16:S637
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
First line therapy
business.industry
Internal medicine
medicine
Imprime PGG
Phases of clinical research
Pembrolizumab
Stage iv
business

Full Text Access

Tools